(Q53211169)

12 May 2018

title

Focal uptake of 68Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumours? (English)

1 reference

12 May 2018

0 references

4

1 reference

12 May 2018

Markus Schwaiger

object named as

Markus Schwaiger

7

0 references

Klemens Scheidhauer

8

object named as

Klemens Scheidhauer

1 reference

12 May 2018

Akram Al-Ibraheem

1

object named as

Akram Al-Ibraheem

1 reference

12 May 2018

author name string

Ralph Alexander Bundschuh

2

1 reference

12 May 2018

Johannes Notni

3

1 reference

12 May 2018

Anna Winter

5

1 reference

12 May 2018

Hans-Jürgen Wester

6

1 reference

12 May 2018

publication date

27 July 2011

1 reference

12 May 2018

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

12 May 2018

volume

38

1 reference

12 May 2018

issue

11

1 reference

12 May 2018

page(s)

2005-2013

1 reference

12 May 2018

Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours

cites work

1 reference

12 December 2020

Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy

1 reference

12 December 2020

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

1 reference

12 December 2020

68Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax.

1 reference

12 December 2020

Evaluation of Positron Emission Tomography Imaging Using [68Ga]-DOTA-D Phe1-Tyr3-Octreotide in Comparison to [111In]-DTPAOC SPECT. First Results in Patients with Neuroendocrine Tumors

1 reference

12 December 2020

[123I]Mtr-TOCA, a radioiodinated and carbohydrated analogue of octreotide: scintigraphic comparison with [111In]octreotide

1 reference

12 December 2020

Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis

1 reference

12 December 2020

Monitoring response to therapeutic interventions in patients with cancer

1 reference

12 December 2020

Misalignment in PET/CT: relevance for SUV and therapy management.

1 reference

12 December 2020

Somatostatin receptor PET imaging with Gallium-68 labeled peptides

1 reference

12 December 2020

Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

1 reference

12 December 2020

Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system.

1 reference

12 December 2020

A 5-decade analysis of 13,715 carcinoid tumors

1 reference

12 December 2020

Abdominal organ motion measured using 4D CT.

1 reference

12 December 2020

Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours

1 reference

12 December 2020

Effect of respiratory gating on quantifying PET images of lung cancer.

1 reference

12 December 2020

Gluc-Lys([18F]FP)-TOCA PET in patients with SSTR-positive tumors: biodistribution and diagnostic evaluation compared with [111In]DTPA-octreotide.

1 reference

12 December 2020

Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data

1 reference

12 December 2020

10.1007/S00259-011-1875-0

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018